Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04678362
Title TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma (TALASUR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Francois Baclesse
Indications

ureter transitional cell carcinoma

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

Therapies

Avelumab + Talazoparib

Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de Cancérologie de l'Ouest Recruiting Angers France Details
CHU Jean Minjoz Recruiting Besançon France Details
Centre François baclesse Active, not recruiting Caen 14000 France Details
Centre Jean Perrin Recruiting Clermont-Ferrand France Details
Centre George-François Leclerc Recruiting Dijon France Details
Centre Léon Bérard Recruiting Lyon France Details
Hospices civils de Lyon Active, not recruiting Lyon France Details
Institut Paoli Calmettes Not yet recruiting Marseille France Details
Institut de Cancérologie de l'Ouest Recruiting Nantes France Details
Centre Antoine Lacassagne Recruiting Nice France Details
Croix Saint-Simon Diaconesses Recruiting Paris France Details
Hopital Tenon Recruiting Paris France Details
Centre Eugène Marquis Recruiting Rennes France Details
IUCT Recruiting Toulouse France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field